These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2173865

  • 21. [Infectious complications due to immunosuppression in organ transplant patients].
    Morelon E, Touraine JL.
    Rev Prat; 2007 Oct 15; 57(15):1677-86. PubMed ID: 18080426
    [Abstract] [Full Text] [Related]

  • 22. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R, Minoli L, Parolini M, Gavazzeni G, Gentile M, Grossi P, Livi U, Parisi F, Utili R.
    J Heart Lung Transplant; 1996 Feb 15; 15(2):124-35. PubMed ID: 8672515
    [Abstract] [Full Text] [Related]

  • 23. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C, Pascual M.
    Clin Infect Dis; 2008 Mar 01; 46(5):732-40. PubMed ID: 18220478
    [Abstract] [Full Text] [Related]

  • 24. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation.
    Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L.
    J Heart Lung Transplant; 1992 Mar 01; 11(5):847-66. PubMed ID: 1420232
    [Abstract] [Full Text] [Related]

  • 25. Postoperative infectious complications of abdominal solid organ transplantation.
    Hlava N, Niemann CU, Gropper MA, Melcher ML.
    J Intensive Care Med; 2009 Mar 01; 24(1):3-17. PubMed ID: 19017663
    [Abstract] [Full Text] [Related]

  • 26. [Infections in renal transplant recipients in Norway].
    Midtvedt K.
    Tidsskr Nor Laegeforen; 1999 Oct 10; 119(24):3621-3. PubMed ID: 10563182
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 10; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 28. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Dec 10; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 29. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P, Kübrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M.
    Circulation; 2004 Sep 14; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [Abstract] [Full Text] [Related]

  • 30. Infectious complications in three double hand recipients: experience from a single center.
    Bonatti H, Brandacher G, Margreiter R, Schneeberger S.
    Transplant Proc; 2009 Mar 14; 41(2):517-20. PubMed ID: 19328916
    [Abstract] [Full Text] [Related]

  • 31. [Sense and nonsense in infection prevention following organ transplantation].
    Schaad HJ, Malinverni R.
    Ther Umsch; 1995 Sep 14; 52(9):608-16. PubMed ID: 7502267
    [Abstract] [Full Text] [Related]

  • 32. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
    Moreno de la Higuera Díaz MA, Calvo Romero N, Sánchez-Fructuoso A, Conesa J, Marques Vidas M, Prats D, Barrientos Guzmán A.
    Transplant Proc; 2007 Sep 14; 39(7):2231-2. PubMed ID: 17889147
    [Abstract] [Full Text] [Related]

  • 33. Infection after liver transplantation.
    Markin RS, Stratta RJ, Woods GL.
    Am J Surg Pathol; 1990 Sep 14; 14 Suppl 1():64-78. PubMed ID: 2183644
    [Abstract] [Full Text] [Related]

  • 34. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V, Barbui A, Franchello A, Varetto S, Pittaluga F, Bobbio M, Salizzoni M, Marchiaro G.
    J Med Virol; 2004 Jun 14; 73(2):223-9. PubMed ID: 15122796
    [Abstract] [Full Text] [Related]

  • 35. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation.
    Havel MP, Laczkovics AM, Wolner E, Kurz RW, Popow-Kraupp T.
    Clin Ther; 1989 Jun 14; 11(4):472-8. PubMed ID: 2550134
    [Abstract] [Full Text] [Related]

  • 36. [Infectious complications after renal transplantation].
    Viale P, Scudeller L.
    G Ital Nefrol; 2004 Jun 14; 21 Suppl 26():S48-52. PubMed ID: 15732046
    [Abstract] [Full Text] [Related]

  • 37. Viral infections in transplant recipients.
    Razonable RR, Eid AJ.
    Minerva Med; 2009 Dec 14; 100(6):479-501. PubMed ID: 20010483
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial prophylaxis regimens following transplantation.
    Subramanian AK.
    Curr Opin Infect Dis; 2011 Aug 14; 24(4):344-9. PubMed ID: 21673573
    [Abstract] [Full Text] [Related]

  • 39. Viral infections in pediatric solid organ transplantation recipients and the impact of molecular diagnostic testing.
    Madan RP, Herold BC.
    Curr Opin Organ Transplant; 2010 Jun 14; 15(3):293-300. PubMed ID: 20445449
    [Abstract] [Full Text] [Related]

  • 40. Infection prevention in solid organ transplantation.
    Gavaldà J, Vidal E, Lumbreras C.
    Enferm Infecc Microbiol Clin; 2012 Mar 14; 30 Suppl 2():27-33. PubMed ID: 22542032
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.